This inventor holds 1 USPTO granted patent. Top assignee: Licestia Ltd.. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Dmitri Poteriaev: Innovator in GDNF Signaling Pathways
Introduction
Dmitri Poteriaev is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of cellular signaling, particularly through his innovative research and patent work.
Latest Patents
Dmitri holds a patent titled "Ret-independent signaling pathway for GDNF." This patent describes methods for screening agonists and antagonists of GPI-anchored independent intracellular signaling. The methods result in [Ca] elevation, ERK1, ERK2, and CREB phosphorylation, as well as Src family kinase activation. Additionally, the patent outlines treatment methods involving the administration of these agonists and antagonists.
Career Highlights
Dmitri is associated with Licestia Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in therapeutic settings.
Collaborations
Dmitri has collaborated with notable colleagues, including Alexey Vladimirovich Titievsky and Urmas Arumäe. These partnerships have contributed to the depth and breadth of his research endeavors.
Conclusion
Dmitri Poteriaev's innovative work in GDNF signaling pathways exemplifies the impact of research on therapeutic advancements. His contributions continue to shape the landscape of cellular signaling research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile